Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


03.07.2017

1 AJR Am J Roentgenol
1 Ann Oncol
1 Cancer
1 Cancer Cell
1 Cancer Res
1 Cancer Sci
4 Clin Lung Cancer
2 Int J Cancer
1 Int J Oncol
1 J Thorac Cardiovasc Surg
2 J Thorac Oncol
1 Lancet Oncol
1 Mol Cancer Ther
2 Mol Carcinog
3 Oncol Rep
1 PLoS Biol
1 PLoS Comput Biol
3 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. WANG GX, Guo LQ, Gainor JF, Fintelmann FJ, et al
    Immune Checkpoint Inhibitors in Lung Cancer: Imaging Considerations.
    AJR Am J Roentgenol. 2017 Jun 28:1-9. doi: 10.2214/AJR.16.17770.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. TOMITA Y, Sueta D, Kakiuchi Y, Saeki S, et al
    Acute Coronary Syndrome as a Possible Immune-Related Adverse Event in a Lung Cancer Patient Achieving a Complete Response to Anti-PD-1 Immune Checkpoint Antibody.
    Ann Oncol. 2017 Jun 23. doi: 10.1093.
    PubMed     Text format    


    Cancer

  3. GOLDSTEIN DA, Bilal U, Prasad V
    Pembrolizumab as first-line therapy in programmed death ligand 1-positive advanced lung cancer: Is it as effective as we think it is?
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30868.
    PubMed     Text format    


    Cancer Cell

  4. BERNS K, Berns A
    Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLC.
    Cancer Cell. 2017;31:169-171.
    PubMed     Text format     Abstract available


    Cancer Res

  5. RICHER AL, Cala JM, O'Brien K, Carson VM, et al
    WEE1 kinase inhibitor AZD1775 has pre-clinical efficacy in LKB1-deficient non-small cell lung cancer.
    Cancer Res. 2017 Jun 26. pii: canres.3565.2016.
    PubMed     Text format     Abstract available


    Cancer Sci

  6. OTSUBO K, Nosaki K, Imamura CK, Ogata H, et al
    Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small cell lung cancer.
    Cancer Sci. 2017 Jul 1. doi: 10.1111/cas.13309.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  7. RAJUPET S, Doshi D, Wisnivesky JP, Lin JJ, et al
    Attitudes About Lung Cancer Screening: Primary Care Providers Versus Specialists.
    Clin Lung Cancer. 2017 May 10. pii: S1525-7304(17)30138.
    PubMed     Text format     Abstract available

  8. MCGEE SF, Zhang T, Jonker H, Laurie SA, et al
    The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30167.
    PubMed     Text format     Abstract available

  9. UMAKOSHI H, Iwano S, Yokoi K, Ito S, et al
    FDG PET/CT Overcomes Discordance Between Clinical and Pathologic TNM Classification of Small-size Primary Lung Cancer: Influence on Postoperative Prognosis.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30170.
    PubMed     Text format     Abstract available

  10. RAZ DJ, Wu GX, Consunji M, Nelson RA, et al
    The Effect of Primary Care Physician Knowledge of Lung Cancer Screening Guidelines on Perceptions and Utilization of Low-Dose Computed Tomography.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30148.
    PubMed     Text format     Abstract available


    Int J Cancer

  11. GOLDWASSER DL
    Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST).
    Int J Cancer. 2017;140:1280-1292.
    PubMed     Text format     Abstract available

  12. SHI H, Zhang J, Han X, Li H, et al
    Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1beta-mediated increase in E-selectin expression.
    Int J Cancer. 2017;140:1370-1383.
    PubMed     Text format     Abstract available


    Int J Oncol

  13. GU Z, Fang X, Li C, Chen C, et al
    Increased PTPRA expression leads to poor prognosis through c-Src activation and G1 phase progression in squamous cell lung cancer.
    Int J Oncol. 2017 Jun 23. doi: 10.3892/ijo.2017.4055.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  14. ZHAO Y, Li G, Zhang Y, Hu H, et al
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 20. pii: S0022-5223(17)31049.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  15. GUPTA A, Saltarski JM, White MA, Scaglioni PP, et al
    Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer.
    J Thorac Oncol. 2017 Jun 21. pii: S1556-0864(17)30466.
    PubMed     Text format     Abstract available

  16. GORE EM, Hu C, Sun AY, Grimm DF, et al
    Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone To Prophylactic Cranial Irradiation And Consolidative Extra-Cranial Irradiation For Extensive Disease Small Cell Lung Cancer (ED-SCLC): NRG Oncology RTOG 0937.
    J Thorac Oncol. 2017 Jun 22. pii: S1556-0864(17)30468.
    PubMed     Text format     Abstract available


    Lancet Oncol

  17. BROWER V
    Atezolizumab in advanced non-small-cell lung cancer.
    Lancet Oncol. 2017 Jun 22. pii: S1470-2045(17)30504.
    PubMed     Text format    


    Mol Cancer Ther

  18. HAAK AJ, Appleton KM, Lisabeth EM, Misek SA, et al
    Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
    Mol Cancer Ther. 2017;16:193-204.
    PubMed     Text format     Abstract available


    Mol Carcinog

  19. YOU BR, Park WH
    Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
    Mol Carcinog. 2017 Jul 1. doi: 10.1002/mc.22701.
    PubMed     Text format     Abstract available

  20. ZHANG X, Cai L, Zhou H, Liu Y, et al
    Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
    Mol Carcinog. 2017 Jul 1. doi: 10.1002/mc.22700.
    PubMed     Text format     Abstract available


    Oncol Rep

  21. ZHANG Z, Rui W, Wang ZC, Liu DX, et al
    Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
    Oncol Rep. 2017 Jun 27. doi: 10.3892/or.2017.5760.
    PubMed     Text format     Abstract available

  22. TANG Y, He R, An J, Deng P, et al
    lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP.
    Oncol Rep. 2017 Jun 26. doi: 10.3892/or.2017.5751.
    PubMed     Text format     Abstract available

  23. CHENG R, Lu C, Zhang G, Zhang G, et al
    Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
    Oncol Rep. 2017;37:2129-2136.
    PubMed     Text format     Abstract available


    PLoS Biol

  24. WEEDEN CE, Chen Y, Ma SB, Hu Y, et al
    Lung Basal Stem Cells Rapidly Repair DNA Damage Using the Error-Prone Nonhomologous End-Joining Pathway.
    PLoS Biol. 2017;15:e2000731.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  25. MATSUI Y, Niida A, Uchi R, Mimori K, et al
    phyC: Clustering cancer evolutionary trees.
    PLoS Comput Biol. 2017;13:e1005509.
    PubMed     Text format     Abstract available


    PLoS One

  26. DE MARCO C, Laudanna C, Rinaldo N, Oliveira DM, et al
    Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
    PLoS One. 2017;12:e0178865.
    PubMed     Text format     Abstract available

  27. ZHANG L, Wang L, Tian P, Tian S, et al
    Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
    PLoS One. 2016;11:e0165543.
    PubMed     Text format     Abstract available

  28. LOISELLE JJ, Roy JG, Sutherland LC
    RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.
    PLoS One. 2017;12:e0180258.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  29. GOCHEVA V, Naba A, Bhutkar A, Guardia T, et al
    Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.
    Proc Natl Acad Sci U S A. 2017 Jun 26. pii: 201707054.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: